Nonetheless, significant observations of the acute TTP patients enrolled confirmed that blocking the A1 domain of the VWF had the potential to increase platelet counts when used in combination with plasma-exchange therapy [100]. The gene discussed is VWF; the disease is thrombotic thrombocytopenic purpura.